| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
gap junction protein beta 2 | 0.441 | 0.846 | 6.6E-16 |
|
disease | 0.100 | None | 0.985 | 66 | 4 | 1998 | 2019 | ||||||||
|
solute carrier family 26 member 4 | 0.507 | 0.885 | 9.0E-22 |
|
disease | 0.100 | None | 1.000 | 18 | 2 | 1997 | 2019 | ||||||||
|
gap junction protein beta 6 | 0.528 | 0.808 | 1.7E-07 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 2003 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily Q member 1 | 0.485 | 0.769 | 4.5E-08 |
|
disease | 0.060 | None | 1.000 | 6 | 1 | 1997 | 2010 | ||||||||
|
myosin VIIA | 0.585 | 0.423 | 1.6E-38 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1996 | 2018 | ||||||||
|
potassium voltage-gated channel subfamily E regulatory subunit 1 | 0.588 | 0.615 | 3.4E-03 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1996 | 2011 | ||||||||
|
POU class 3 homeobox 4 | 0.633 | 0.654 | 0.57 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2009 | 2015 | ||||||||
|
transmembrane serine protease 3 | 0.650 | 0.538 | 6.1E-11 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2016 | ||||||||
|
usherin | 0.579 | 0.692 | 1.6E-94 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2017 | ||||||||
|
transmembrane channel like 1 | 0.769 | 0.346 | 9.2E-19 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2019 | ||||||||
|
myosin XVA | 0.722 | 0.346 | 1.3E-56 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2001 | ||||||||
|
cadherin related 23 | 0.539 | 0.769 | 3.2E-06 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2011 | 2016 | ||||||||
|
ATPase plasma membrane Ca2+ transporting 2 | 0.659 | 0.731 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2018 | ||||||||
|
solute carrier family 17 member 8 | 0.729 | 0.462 | 1.3E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2019 | ||||||||
|
fibroblast growth factor 3 | 0.505 | 0.808 | 9.3E-05 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2009 | ||||||||
|
potassium voltage-gated channel subfamily Q member 3 | 0.604 | 0.462 | 0.80 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2008 | ||||||||
|
LHFPL tetraspan subfamily member 5 | 0.861 | 0.192 | 4.0E-04 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
small muscle protein X-linked | 0.682 | 0.500 | 0.62 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2017 | 2019 | ||||||||
|
prostaglandin D2 synthase | 0.503 | 0.846 | 5.1E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1998 | 2000 | ||||||||
|
calcium voltage-gated channel subunit alpha1 D | 0.582 | 0.577 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2014 | ||||||||
|
potassium voltage-gated channel subfamily Q member 4 | 0.674 | 0.462 | 0.47 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2008 | ||||||||
|
tectorin alpha | 0.700 | 0.385 | 3.0E-16 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2016 | ||||||||
|
ankyrin repeat domain 7 | 0.890 | 0.346 | 4.3E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
mitochondrial ribosomal protein S7 | 0.722 | 0.500 | 1.3E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
paired box 3 | 0.481 | 0.769 | 0.24 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 |